VolitionRx (VNRX) Institutional Ownership $0.66 +0.07 (+12.61%) (As of 03:57 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for VolitionRx (NYSE:VNRX)CurrentInstitutional OwnershipPercentage8.09%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$174.83KNumber ofInstitutional Sellers(last 12 months)0 Get VNRX Insider Trade Alerts Want to know when executives and insiders are buying or selling VolitionRx stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.>> Register for the Workshop Now VolitionRx Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024 Geode Capital Management LLC730,448$439K0.0%+15.1%0.788% 10/29/2024 Ground Swell Capital LLC45,959$28K0.0%+78.8%0.050% 1/17/2024 Silverberg Bernstein Capital Management LLC147,038$105K0.1%N/A0.187% 11/14/2023 Lagoda Investment Management L.P.3,882,850$2.68M1.8%-1.2%4.969% (Data available from 1/1/2016 forward) VNRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VNRX shares? During the previous two years, the following institutional investors and hedge funds held shares of VolitionRx shares: Lagoda Investment Management L.P. ($2.68M), Geode Capital Management LLC ($439K), and Silverberg Bernstein Capital Management LLC ($105K), Ground Swell Capital LLC ($28K).Learn more on VNRX's institutional investors. What percentage of VolitionRx stock is owned by institutional investors? 8.09% of VolitionRx stock is owned by institutional investors. Learn more on VNRX's institutional investor holdings. Which institutional investors have been buying VolitionRx stock? The following institutional investors have purchased VolitionRx stock in the last 24 months: Silverberg Bernstein Capital Management LLC ($147.04K), Geode Capital Management LLC ($95.90K), and Ground Swell Capital LLC ($20.25K). How much institutional buying is happening at VolitionRx? Institutional investors have bought a total of 263,187 shares in the last 24 months. This purchase volume represents approximately $174.83K in transactions. Which VolitionRx major shareholders have been selling company stock? The following institutional investors have sold VolitionRx stock in the last 24 months: Lagoda Investment Management L.P. ($46.26K). How much institutional selling is happening at VolitionRx? Institutional investors have sold a total of 46,260 shares in the last 24 months. This volume of shares sold represents approximately $31.87K in transactions. Related Companies FULC Major Shareholders ACB Major Shareholders FATE Major Shareholders LXEO Major Shareholders DMAC Major Shareholders ZNTL Major Shareholders ATAI Major Shareholders TNYA Major Shareholders ACRS Major Shareholders ACRV Major Shareholders This page (NYSE:VNRX) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredAI Crypto Tool Could Send One Coin SOARING…The #1 AI Coin to Buy Rapid growth predicted for little-known AI crypto projectCrypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VolitionRx Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share VolitionRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
